Home›Search›Stem Cell Research and Therapy

Stem Cell Research and Therapy

BioMed Central Ltd · United Kingdom · Est. 1968

ISSN1757-6512eISSN1757-6512

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

179

days submission → published

measured · last 18 articles · accept 156d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.939

H-Indexi

175

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.427

Total Worksi

5,463

Total Citationsi

217,009

2yr Mean Citednessi

5.68

Open Impact Factor alternative

Aims & Scope

Subject areas: Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental; Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Molecular Medicine.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1968

Annual Volume~ 551 articles / year

StatusActive (last: 2026)

Total Publications5,463

Publisher OrgBioMed Central

OA Since2009

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~16 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

LOCKSSPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

BioMed Central Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1757-6512 / 1757-6512

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

LOCKSS, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

408

29k

2019

532

29k

2020

609

26k

2021

535

18k

2022

383

2023

506

6.3k

2024

764

3.8k

2025

263

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1

Cell BiologyQ1

Medicine (miscellaneous)Q1

Molecular MedicineQ1

Subject Classification

Web of Science Categories

Cell & Tissue EngineeringCell BiologyMedicine, Research & Experimental

Scopus Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Medicine (miscellaneous)Molecular MedicineCell Biology

Research Topics (OpenAlex)

Mesenchymal stem cell researchPluripotent Stem Cells ResearchTissue Engineering and Regenerative MedicineExtracellular vesicles in diseaseCancer Cells and MetastasisWound Healing and TreatmentsMicroRNA in disease regulationNeurogenesis and neuroplasticity mechanismsOsteoarthritis Treatment and MechanismsAngiogenesis and VEGF in Cancer

Frequently asked questions about Stem Cell Research and Therapy

Is Stem Cell Research and Therapy a predatory journal?

PubScope has no integrity flags on record for Stem Cell Research and Therapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Stem Cell Research and Therapy?

Stem Cell Research and Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 5.68.

Is Stem Cell Research and Therapy indexed in Scopus and Web of Science?

Stem Cell Research and Therapy is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Stem Cell Research and Therapy?